Wealthcare Capital Management’s Biogen BIIB Stock Holding History

Wealthcare Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14	Closed	-$4K	–	146
2021 Q1	$4K	Buy	+14	New	+$3.78K	﹤0.01%	404
2020 Q1	–	Sell	-14	Closed	-$4K	–	291
2019 Q4	$4K	Buy	+14	New	+$3.88K	﹤0.01%	273
2016 Q4	–	Sell	-9	Closed	-$3K	–	189
2016 Q3	$3K	Hold	9	–	–	﹤0.01%	159
2016 Q2	$2K	Hold	9	–	–	﹤0.01%	163
2016 Q1	$2K	Hold	9	–	–	﹤0.01%	173
2015 Q4	$3K	Hold	9	–	–	﹤0.01%	180
2015 Q3	$3K	Hold	9	–	–	﹤0.01%	197
2015 Q2	$4K	Sell	9 -113	-93%	-$45.4K	﹤0.01%	277
2015 Q1	$52K	Buy	+122	New	+$48.1K	0.01%	245

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wealthcare Capital Management's BIIB Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Biogen (BIIB) in Q2 2021, closing a stake of 14 shares — an estimated $4K sold.

Wealthcare Capital Management first reported a position in BIIB in Q1 2015 and held it in 9 quarters. The position peaked at $52K in Q1 2015. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

Wealthcare Capital Management reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
Wealthcare Capital Management sold 14 Biogen shares in Q2 2021, an estimated $4K.
Wealthcare Capital Management first reported a position in Biogen in Q1 2015 and held it in 9 quarters.
Wealthcare Capital Management's Biogen position peaked at $52K in Q1 2015.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.